Capital Advisors Ltd’s Definitive Healthcare DH Stock Holding History

Capital Advisors Ltd’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28	Closed	–	–	1340
2023 Q1	$0	Sell	28 -769	-96%	-$9.05K	﹤0.01%	1270
2022 Q4	$0	Buy	+797	New	+$10.2K	﹤0.01%	1304

Other funds holding DH

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Capital Advisors Ltd's DH Position: Q2 2023 in Review

Capital Advisors Ltd sold out of Definitive Healthcare (DH) in Q2 2023, closing a stake of 28 shares.

Capital Advisors Ltd first reported a position in DH in Q4 2022 and held it in 2 quarters. The position peaked at $0 in Q1 2023. 137 funds tracked by Wall St. Rank hold DH as of Q2 2023.

Capital Advisors Ltd reported no remaining Definitive Healthcare position as of Q2 2023 after selling out during the quarter.
Capital Advisors Ltd sold 28 Definitive Healthcare shares in Q2 2023.
Capital Advisors Ltd first reported a position in Definitive Healthcare in Q4 2022 and held it in 2 quarters.
Capital Advisors Ltd's Definitive Healthcare position peaked at $0 in Q1 2023.
137 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2023.

Based on Capital Advisors Ltd's 13F filing for Q2 2023, filed 26 Jul 2023.